At the news
? NEUTRALIMPACT 2/10 144 filed Nov 6, 2026 at 16:32 ET
Keeley Cain Wettan, an officer of Gilead Sciences, filed a Form 144 to sell 3,399 shares of common stock with an approximate market value of $569,570. The shares were acquired through vesting of restricted stock units between August and September 2026. The sale is a routine disposition of equity compensation by an insider, representing a negligible fraction of the company's $216.4B market cap.
- Insider: Keeley Cain Wettan, officer of Gilead Sciences
- Shares to be sold: 3,399 shares of common stock
- Estimated value: $569,570.43
- Shares acquired via vesting of restricted stock units from 08/10/2026 through 09/10/2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access